• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者肿瘤大小与生存的相关因素:血小板-淋巴细胞比值、门静脉血栓形成及白蛋白的意义

Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin.

作者信息

Donghia Rossella, Carr Brian Irving, Yilmaz Sezai

机构信息

National Institute of Gastroenterology - IRCCS "Saverio de Bellis", Castellana Grotte, Italy.

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

出版信息

Oncology. 2025 Apr 8:1-11. doi: 10.1159/000545636.

DOI:10.1159/000545636
PMID:40199256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12353039/
Abstract

INTRODUCTION

Maximum tumor diameter (MTD) is one of the key aggressiveness features of hepatocellular carcinoma (HCC). However, the clinical associations and causes of large size HCC are not well understood. The aim was to compare small and large MTD (≤/>6 cm) HCCs with respect to clinical associations.

METHODS

MTD ≤/> 6 cm HCCs were compared by clinical characteristics and analyzed through logistical regression models, as well as Cox proportional hazard models for death, on clinical parameters.

RESULTS

Patients with larger HCCs had more portal vein thrombosis (PVT) and tumor multifocality, higher AST, ALKP and GGT levels and lower albumin levels. A logistic regression model of MTD (≤/>6 cm) showed the highest risk for PVT and platelet-lymphocyte ratio (PLR) >150, while albumin and female gender were protective. The combination of male gender, PLR >150, plus PVT had an odds ratio of 12.124. In Cox proportional hazard models, the highest hazard ratio for death was for PVT, and only albumin was significantly protective. PVT plus low albumin had a hazard ratio of 4.254.

CONCLUSION

PVT, albumin, PLR, and gender were significant for ≤/>6 cm MTD. PVT and albumin were significant for survival.

摘要

引言

最大肿瘤直径(MTD)是肝细胞癌(HCC)的关键侵袭性特征之一。然而,大尺寸HCC的临床关联和病因尚未完全明确。本研究旨在比较小MTD(≤6 cm)和大MTD(>6 cm)HCC的临床关联。

方法

根据临床特征对MTD≤/ >6 cm的HCC进行比较,并通过逻辑回归模型以及针对临床参数的死亡的Cox比例风险模型进行分析。

结果

大尺寸HCC患者的门静脉血栓形成(PVT)和肿瘤多灶性更多,AST、ALKP和GGT水平更高,白蛋白水平更低。MTD(≤/ >6 cm)的逻辑回归模型显示,PVT和血小板淋巴细胞比率(PLR)>150的风险最高,而白蛋白和女性性别具有保护作用。男性、PLR>150加上PVT的组合的优势比为12.124。在Cox比例风险模型中,死亡的最高风险比是PVT,只有白蛋白具有显著的保护作用。PVT加上低白蛋白的风险比为4.254。

结论

PVT、白蛋白、PLR和性别对于MTD≤/ >6 cm具有重要意义。PVT和白蛋白对生存具有重要意义。

相似文献

1
Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin.肝细胞癌患者肿瘤大小与生存的相关因素:血小板-淋巴细胞比值、门静脉血栓形成及白蛋白的意义
Oncology. 2025 Apr 8:1-11. doi: 10.1159/000545636.
2
Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival.伴有门静脉血栓形成的肝癌患者的特征:白蛋白与生存情况。
Oncology. 2024 Dec 9:1-10. doi: 10.1159/000542774.
3
Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival.肝细胞癌肿瘤体积倍增时间的影响因素分析及其对无进展生存期的预测价值
Sci Rep. 2025 Jul 16;15(1):25840. doi: 10.1038/s41598-025-06349-3.
4
Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma.血管侵犯性肝细胞癌机器人放射外科治疗后门静脉肿瘤血栓反应与生存功能的相关性
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101404. doi: 10.1016/j.jceh.2024.101404. Epub 2024 Mar 29.
5
Correlation between virological response and portal vein thrombosis in patients with chronic hepatitis B.慢性乙型肝炎患者病毒学应答与门静脉血栓形成之间的相关性
Sci Rep. 2025 Jul 1;15(1):20856. doi: 10.1038/s41598-025-04316-6.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Small hepatocellular carcinomas and thrombocytopenia.小肝癌和血小板减少症。
Oncology. 2012;83(6):331-8. doi: 10.1159/000341533. Epub 2012 Sep 18.
10
Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis.肝硬化合并门静脉血栓形成患者肠道及循环微生物群特征分析
Front Microbiol. 2025 Jun 19;16:1597145. doi: 10.3389/fmicb.2025.1597145. eCollection 2025.

引用本文的文献

1
Crystal Ball in a Blood's Drop: Unlocking Hidden Prognostic Power in the Neutrophil-to-Lymphocyte Ratio (NLR) and the Platelet-to-Lymphocyte Ratio (PLR) for Elderly Hip Fracture Patients.血滴中的水晶球:揭示中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)对老年髋部骨折患者的潜在预后价值
J Clin Med. 2025 May 20;14(10):3584. doi: 10.3390/jcm14103584.

本文引用的文献

1
Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation.局部肝脏放射消融治疗肝癌病灶在热消融范围内外的疗效和安全性。
Dig Dis. 2024;42(5):461-472. doi: 10.1159/000538788. Epub 2024 May 23.
2
Alpha-fetoprotein and albumin inversely relate to each other and to tumor parameters in patients with hepatocellular carcinoma.在肝细胞癌患者中,甲胎蛋白和白蛋白相互呈负相关,且与肿瘤参数也呈负相关。
Hepatol Forum. 2024 Jan 16;5(1):11-17. doi: 10.14744/hf.2023.2023.0023. eCollection 2024.
3
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma.
肝细胞癌中的肿瘤微环境组成及相关治疗
J Hepatocell Carcinoma. 2023 Nov 21;10:2083-2099. doi: 10.2147/JHC.S436962. eCollection 2023.
4
Identification of 2 large size HCC phenotypes, with and without associated inflammation.识别出两种大尺寸肝癌表型,一种伴有炎症,另一种不伴有炎症。
Clin Pract (Lond). 2022;19(4):1953-1958. Epub 2022 Jun 7.
5
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.肝细胞癌中的血管生成:机制与抗血管生成治疗。
Cancer Biol Med. 2023 Jan 12;20(1):25-43. doi: 10.20892/j.issn.2095-3941.2022.0449.
6
Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.肝癌中的肿瘤干细胞:干性调控的内在和外在分子机制。
Int J Mol Sci. 2022 Oct 14;23(20):12327. doi: 10.3390/ijms232012327.
7
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma.肝癌免疫微环境:对肝细胞癌的治疗意义。
Hepatology. 2023 May 1;77(5):1773-1796. doi: 10.1002/hep.32740. Epub 2023 Apr 17.
8
Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan.基于白蛋白-胆红素分级的新型新格拉斯哥预后评分与目前用于肝细胞癌手术切除后预后预测的营养指标的比较:日本的一项多中心回顾性研究
Cancers (Basel). 2022 Apr 22;14(9):2091. doi: 10.3390/cancers14092091.
9
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.肝细胞癌的肿瘤微环境:新治疗方案面临的挑战与机遇
Int J Mol Sci. 2022 Mar 29;23(7):3778. doi: 10.3390/ijms23073778.
10
Predictive Value of Platelet-Related Measures in Patients with Hepatocellular Carcinoma.血小板相关指标对肝细胞癌患者的预测价值。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211064414. doi: 10.1177/15330338211064414.